MDbio starts clinical trials for pharma-grade products that target sleeplessness, stress and pain

MDbio, in collaboration with research partners at Radicle Science, is initiating three separate clinical trials to evaluate the effectiveness of their new plant-based products targeting sleeplessness, pain, and stress. The trials aim to assess the synergistic outcomes of multi-active formula compounds and determine the impact of drug holidays using plant-based medicines. MDsleep™, MDrelief™, and MDcalm™ will be tested on more than 2,500 US adults over a four-week period. These products have already undergone internal observational trials and have shown promising results when used by patients suffering from the respective conditions.

Read More